Skip to content

Budesonide EP Impurity C

Budesonide EP Impurity C

Product Description
CAT No.
ALN-B022004
CAS No.
1040085-99-1
Mol. F.
C25H34O6
Mol. Wt.
430.4
Stock
Please Inquire
Chemical Name : 16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione (as per EP & USP)
Smiles : O=C(C=C[C@]1(C)[C@@]2([H])[C@@H](O)C[C@@]34C)C=C1CC[C@@]2([H])[C@]3([H])C[C@]5([H])[C@@](C4=O)(CO)OC(CCC)O5
Inchi : InChI=1S/C23H30O6/c1-12-28-19-9-16-15-5-4-13-8-14(25)6-7-21(13,2)20(15)17(26)10-22(16,3)23(19,29-12)18(27)11-24/h6-8,12,15-17,19-20,24,26H,4-5,9-11H2,1-3H3/t12?,15-,16-,17-,19+,20+,21-,22-,23+/m0/s1
Synonym : d-homobudesonide (USP) ; Budesonide d-homo analog (USP)

A validated stability indicating UHPLC method for the determination of anti-inflammatory corticosteroid budesonide epimers

By Vaddi, Lakshmi; Purushothaman, Vijayanthimala; Gowda, NagarajnFrom Journal of Pharmaceutical Sciences and Research (2020), 12(6), 848-852

Analytical method development and validation of formoterol fumarate and budesonide in pressurized meter dose inhaler form by using RP-HPLC

By Raghu, P. S. – From European Journal of Biomedical and Pharmaceutical Sciences (2018), 5(6), 1-6

Isolation and characterization of photodegradation impurity in budesonide drug product using LC-MS and NMR spectroscopy

By Bhutnar, Arun; Khapare, Sachin; Desai, Anita; Dsouza, Smitha – From American Journal of Analytical Chemistry (2017), 8(7), 449-461

Request For Quotation